SCHEMBL7350240

SCHEMBL7350240

CN(C)C1Cc2cc(Br)cc([N+](=O)[O-])c2NC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.35
ALDH1A1 P00352 2/20 0.32
GALR3 O60755 1/20 0.32
GAA P10253 1/20 0.32
S100A4 P26447 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
ERN1 O75460 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
PTGS2 P35354 1/20 0.30
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30
METAP1 P53582 1/20 0.30
MAPT P10636 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14550752 0.83 AKR1B1 (0.37) AKR1B1ALDH1A1GALR3GAAS100A4
SCHEMBL7349533 0.80 AKR1B1 (0.37) AKR1B1ALDH1A1GALR3S100A4TRPV1
Hydrochloric Acid SCHEMBL2839862 0.79 AKR1B1 (0.36) AKR1B1ALDH1A1GALR3S100A4TRPV1
SCHEMBL7346699 0.79 ERN1 (0.36) AKR1B1ALDH1A1S100A4TRPV1ERN1
SCHEMBL2840941 0.76 ALDH1A1 (0.33) AKR1B1ALDH1A1GAAS100A4TRPV1
SCHEMBL7346523 0.75 AKR1B1 (0.36) AKR1B1ALDH1A1GALR3GAAS100A4
SCHEMBL2843494 0.74 GPR35 (0.34) AKR1B1ALDH1A1S100A4TRPV1ERN1
SCHEMBL2843497 0.74 GPR35 (0.34) AKR1B1ALDH1A1S100A4TRPV1ERN1
SCHEMBL13090518 0.72 AKR1B1 (0.37) AKR1B1ALDH1A1S100A4TRPV1ERN1
SCHEMBL1119381 0.71 CYP11B1 (0.54) AKR1B1ALDH1A1S100A4TRPV1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed